Using a clinicopathologic and gene expression model to identify melanoma patients at high risk for disease relapse.

10068Background: The identification of early stage melanoma patients at high risk for relapse is still difficult. Roughly 50% of melanoma deaths occur in patients who were initially diagnosed with ...